ClinicalTrials.gg
Not yet recruitingNCT06780280ORE-DOCUpdated Feb 24, 2025

Walking With Overground Robotic Exoskeletons to Improve Arrousal in Individuals With Disorders of Consciousness

A Phase 2/3 interventional study of Overground Walking in Traumatic Brain Injuries, sponsored by Craig Hospital. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-24.

Sponsored by Craig Hospital · Phase 2/3, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2026, 10 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2/3
Study type
Interventional
Enrollment
25
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Brain Injuries, Traumatic by Craig Hospital — 5 open to participants now, 5 under way, 1 of them phase 3. Brain Injuries, Traumatic · Craig Hospital.

Planned enrollment
13th of 15
25 · median 60
Started
2025
the only one that year
Phase 2/3
Only one
of the 16
Registered
13th of 16
by date

Among the 16 studies in Brain Injuries, Traumatic by Craig Hospital, this one is the 13th largest by planned enrollment of the 15 interventional ones that give a count, is the only one that started in 2025, is the only one in phase 2/3, and was the 13th registered.

Brain Injuries, Traumatic

1,725 studies on the registry are indexed under Brain Injuries, Traumatic; 450 are open to participants now.

Browse Brain Injuries, Traumatic studies →

Open to participants now

5 of the 16 studies in Brain Injuries, Traumatic by Craig Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 287 Brain Injuries, Traumatic studies recruiting now, 126 (44%) set no upper age limit and 119 (41%) stop at 75 or younger; 41 take children under 18; 53 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Brain Injuries, Traumatic by Craig Hospital, or all of them as a file.
02

Study summary

This proposed study will examine a walking intervention to promote changes in conscious state in individuals with disorders of consciousness (DoC) due to acquired brain injury (ABI). Recent practice guidelines highlight the need to develop interventions to arouse patients with DoC, as current treatment options are scarce with limited to low-quality pharmaceutical and electrical stimulation approaches to improve outcomes. New data indicates patients with chronic DoC may benefit from therapeutic intervention prioritizing repeated multimodal sensory (i.e., simultaneous vestibular, proprioceptive, and visual) input, but likely not attain comparable functional recovery to those who demonstrate early command following ability. Interventions activating pathways of the cerebral consciousness network may leverage a substrate for recovery. We hypothesize that walking in an overground robotic exoskeleton (ORE) is safe, feasible, and will simultaneously stimulate endogenous cognitive and automatic pathways associated with walking5 to promote changes in behavioral performance in individuals with DoC.

Read the detailed description

The objective of this study is to evaluate the safety, feasibility and tolerability of using ORE therapy with individuals who meet criteria for DoC during inpatient rehabilitation while evaluating changes in behavioral performance, neurophysiology, and physiologic response to training. DoC numbers are very small so our goal is to gather this pilot data to support a future multi-site efficacy study with other TBIMS Center partners.

03

Conditions studied

  • Traumatic Brain Injuries

Keywords

  • TBI, disorders of consciousness, walking, exoskeletons
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Individuals with DOC who are receiving inpatient rehabilitation

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    Walking Intervention

    Overground walking with an exoskeleton

    Other: Overground Walking

Interventions

  • OtherOverground Walking

    Overground walking with an exoskeleton

06

What researchers measure

Primary outcomes

  1. Adverse Events and feasibility

    We will measure all adverse advents.

    Time frame: four weeks

Secondary outcomes

  1. Coma Recovery Scale-Revised

    Measuring motor subscale, arrousal, and auditory subscales

    Time frame: four weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Pilot study

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Mar 2025; primary completion for Jan 2026, 9 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 13, 2025
First posted
Jan 17, 2025
StartEst.
Mar 20, 2025
Primary completionEst.
Jan 1, 2026
CompletionEst.
Jan 30, 2026
Last update
Feb 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06780280
Lead sponsor
Craig Hospital
Responsible party
Sponsor
First posted
Jan 17, 2025
Start date
Mar 20, 2025 (estimated)
Primary completion
Jan 1, 2026 (estimated)
Completion
Jan 30, 2026 (estimated)
Last update
Feb 24, 2025

Study contacts

Candace Tefertiller, Executive Director of Research, PhD
Contact
ctefertiller@craighospital.org
3037898251
Clare Morey, MS
Contact
cmorey@craighospital.org

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion